Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1

Abstract

Autoimmune polyendocrine syndrome type I (APS‐1) is caused by mutations in the autoimmune regulator (AIRE) gene and characterised clinically by multiple autoimmune manifestations and serologically by autoantibodies against tissue proteins and cytokines. We here hypothesised that lack of AIRE expression in thymus affects blood immune cells and performed whole‐blood microarray analysis (N = 16 APS‐I patients vs 16 controls), qPCR verification, and bioinformatic deconvolution of cell subsets. We identified B cell responses as being downregulated in APS‐1 patients, which was confirmed by qPCR; these results call for further studies on B cells in this disorder. The type I interferon (IFN‐I) pathway was also downregulated in APS‐1, and the presence of IFN antibodies is the likely reason for this mild overall downregulation of the IFN‐I genes in most APS‐1 patients.